TAGRISSO® (tuh-GRISS-oh) (Osimertinib)
- January 1, 2021
- 0
TAGRISSO®
(tuh-GRISS-oh)
(Osimertinib)
Chemotherapy
TAGRISSO®
(tuh-GRISS-oh)
(Osimertinib)
Chemotherapy
What is TAGRISSO (Osimertinib)?
TAGRISSO is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic):
- As your first treatment if your tumor has a certain abnormal epidermal growth factor receptor (EGFR) gene(s) or
- If you have a certain type of EGFR gene and had previous treatment with an EGFR tyrosine kinase inhibitor (TKI) medicine that did not work or is no longer working.
It is not known if TAGRISSO is safe and effective in children.
What is the most important information I should know about TAGRISSO?
TAGRISSO can cause serious side effects. These serious side effects include:
- Lung problems. TAGRISSO may cause lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening lung symptoms, including trouble breathing, shortness of breath, cough, or fever.
- Heart problems, including heart failure. TAGRISSO may cause heart problems that may lead to death. Your doctor should check your heart function before you start taking TAGRISSO and during treatment as needed. Tell your doctor right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing, shortness of breath, swelling of your ankles and feet, feeling lightheaded.
- Eye problems. TAGRISSO may cause eye problems. Tell your doctor right away if you have symptoms of eye problems which may include watery eyes, sensitivity to light, eye pain, eye redness, or vision changes. Your doctor may send you to see an eye specialist (ophthalmologist) if you get eye problems with TAGRISSO.
- The most common side effects of TAGRISSO are:
- Diarrhea
- Rash
- Dry skin
- Mouth sores
- Tiredness
- Decreased appetite
- Changes in your nails, including: redness, tenderness, pain, inflammation, brittleness, separation from nailbed, and shedding of nails
How should I take TAGRISSO?
- Take TAGRISSO exactly as your doctor tells you to take it.
- Your doctor may change your dose, temporarily stop, or permanently stop treatment with TAGRISSO if you have side effects.
- Take TAGRISSO 1 time each day.
- You can take TAGRISSO with or without food.
- If you miss a dose of TAGRISSO, do not make up for the missed dose. Take your next dose at your regular time.
- If you cannot swallow TAGRISSO tablets whole:
- Place your dose of TAGRISSO in a container that contains 60 mL (2 ounces) of water. Do not use carbonated water or any other liquids.
- Stir the TAGRISSO tablet and water until the TAGRISSO tablet is in small pieces (the tablet will not completely dissolve). Do not crush, heat, or use ultrasound to prepare the mixture.
- Drink the TAGRISSO and water mixture right away.
- Add 120 mL to 240 mL (4 to 8 ounces) of water into the container and drink to make sure that you take your full dose of TAGRISSO.
Important Safety Information
- TAGRISSO can harm your unborn baby. Tell your doctor right away if you become pregnant during treatment with TAGRISSO or think you may be pregnant.
- Females who are able to become pregnant should use effective birth control during treatment with TAGRISSO and for 6 weeks after the final dose of TAGRISSO.
- Males who have female partners that are able to become pregnant should use effective birth control during treatment with TAGRISSO and for 4 months after the final dose of TAGRISSO
- It is not known if TAGRISSO passes into your breast milk. Do not breastfeed during treatment with TAGRISSO and for 2 weeks after your final dose of TAGRISSO
What should I tell my healthcare provider before taking TAGRISSO?
Before taking TAGRISSO, tell your doctor about all of your medical conditions, including if you:
- Have lung or breathing problems.
- Have heart problems, including a condition called long QTc syndrome.
- Have problems with your electrolytes, such as sodium, potassium, calcium or magnesium.
- Have a history of eye problems.
- Are pregnant or plan to become pregnant. TAGRISSO can harm your unborn baby. Tell your doctor right away if you become pregnant during treatment with TAGRISSO or think you may be pregnant.
- Are breastfeeding or plan to breastfeed. It is not known if TAGRISSO passes into your breast milk. Do not breastfeed during treatment with TAGRISSO and for 2 weeks after your final dose of TAGRISSO. Talk to your doctor about the best way to feed your baby during this time.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Especially tell your doctor if you take a heart or blood pressure medicine.
Available 24/7
Experiencing
symotoms that
concern you
General information about TAGRISSO
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use TAGRISSO for a condition for which it was not prescribed. Do not give TAGRISSO to other people, even if they have the same symptoms you have. It may harm them.
What are the ingredients in TAGRISSO?
Active ingredient: Osimertinib
Inactive ingredient: Mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, and sodium stearyl fumarate. Tablet coating contains: polyvinyl alcohol, titanium dioxide, macrogol 3350, talc, ferric oxide yellow, ferric oxide red and ferric oxide black
